Live Breaking News & Updates on European Position Paper

Stay updated with breaking news from European position paper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dupilumab improves CRSwNP outcomes across type 2 inflammation profiles

Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany. Treatment also reduced local and systemic type 2 inflammation biomarkers and was well tolerated, Claus Bachert, MD, PhD, department of otorhinolaryngology, head and neck ....

Sanofi Regeneron , Byrichard Gawel , Stallergenes Greer , Claus Bachert , Kristen Dowd , European Forum For Research , Global Initiative For Asthma , Airway Diseases , University Hospital , Sino Nasal Outcome Test , Global Initiative , European Position Paper , Nasal Polyps , European Forum ,